Slide 1: The Future of Protein, Rooted in Nature
The Future of Protein, Rooted in Nature Investor Presentation August 2025
Slide 2: Safe Harbour Statement
Safe Harbour Statement TSX: BU GENERAL Burcon NutraScience Corporation (“Burcon” or, the “Company”) is making this presentation available to selected persons on the terms and conditions set forth below. Any unauthorized use of the presentation is strictly prohibited. Additional information with resp
Slide 3: Innovation Leader in Plant-based Proteins
Innovation Leader in Plant-based Proteins TSX: BU Putting People and Planet First 20+ years of plant protein innovation Our proprietary extraction technology and unique purification process results in differentiated, best-in-class protein ingredients that offer: Fava Products have best-in-class prot
Slide 4: Consumer Interest in Plant Proteins
Consumer Interest in Plant Proteins TSX: BU Traditional Proteins Burcon Ingredient Solutions Meat Proteins Global Plant-based Protein Market Dairy US$64.38B in 2025 Proteins Compound Annual Growth Rate 17.9%¹ Egg Proteins Burcon proteins have unmatched purity, superior taste, color and functionality
Slide 5: Robust Customer Pipeline
Robust Customer Pipeline TSX: BU 150+ Product Samples under Evaluation Multi-million $ Sales Funnel 17 Expression of Interest Letters Moving to final step of commercial 150+ Customer Projects product evaluation Entered into $6.8M Multi-Year Supply Agreements Production Agreement Recurring Revenue Ne
Slide 6: Direct Route to Market
Direct Route to Market TSX: BU Significant Inflection Point for Burcon Burcon NutraScience Key Highlights • Capital-light Business Model • Full control over production • Launch entire product portfolio • 7-Year Manufacturing Agreement • Acquisition closed March 2025 Production Online June 2025 ProMa
Slide 7: Milestones in Last 6 Months
Milestones in Last 6 Months TSX: BU Executing Capital-light Business Plan Official Launch & First Commercial Production – Fava Protein Entered into $6.8 Million Multi-Year Production Agreement 20-to-1 Share Consolidation First Commercial Production – Pea Protein Completed Acquisition of Protein Prod
Slide 8: Investment Opportunity
Investment Opportunity TSX: BU Pieces are in place – now we execute on our plan TSX: BU OTCQB: BRCNF Share Price Projected Gross Margin % $2.88 (August 5, 2025) 80% Phase 3 70% Market Cap $37M (August 5, 2025) 60% Shares 12.7M issued 50% Phase 2 Outstanding 14.9M diluted 40% 30% Insider 30% Phase 1
Slide 9: Looking Ahead
Looking Ahead TSX: BU Building a foundation for future growth Expected Catalysts and Milestones through Calendar 2025/2026 Commercial Sales; Facility Acquisition & Supply Contracts & Significant Recurring Profitable inside 2026 Production Online New Product Launches Revenue 1Q25 1H25 2H25 2026 Miles
Slide 10: Burcon NutraScience
TSX: BU Burcon NutraScience Differentiated Proteins Agtech Pure Play on the TSX Global Agri-Technology Leader 10